ANL
Adlai Nortye Ltd. American Depositary Shares
NASDAQ: ANL · HEALTHCARE · BIOTECHNOLOGY
$14.27
+1.28% today
Updated 2026-04-30
Market cap
$953.09M
P/E ratio
—
P/S ratio
190.62x
EPS (TTM)
$-1.11
Dividend yield
—
52W range
$1 – $17
Volume
0.4M
Adlai Nortye Ltd. American Depositary Shares (ANL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-1.6%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-13.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-17.2%
2025-12-03
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $0.00 | — | $10.12 | $9.19 | -9.2% |
| 2025-12-03 | $0.00 | — | $1.45 | $1.20 | -17.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 | $0.00 | — | — | — |
| 2025-09-30 | $0.00 | $0.00 | — | — | — |
| 2025-06-30 | $0.00 | $-0.18 | — | — | — |
| 2025-03-31 | $-0.63 | $-0.64 | -1.6% | — | — |
| 2024-09-30 | $-0.62 | $0.00 | +100.0% | — | — |
| 2024-06-30 | $-0.61 | $-0.35 | +42.6% | $745000.00 | — |
| 2023-12-31 | $-0.38 | $-0.38 | +0.0% | $2.50M | — |
| 2023-09-30 | $-0.24 | $-0.24 | +0.0% | $2.50M | — |
| 2023-06-30 | $0.00 | $-1.94 | — | — | — |
Frequently asked questions
Has Adlai Nortye Ltd. American Depositary Shares beaten earnings estimates?
Adlai Nortye Ltd. American Depositary Shares has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -1.6% over the last 1 quarters.
How does ANL stock react to earnings?
ANL stock has moved an average of -13.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.